Business
CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center
Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas healthcare is experiencing a historic breakthrough with the approval of House Bill 46 (HB 46). Signed into law on June 21, 2025, by Governor Greg Abbott, the expansion of the Texas Compassionate Use Program (TCUP) will cover chronic pain, PTSD, and degenerative neurological conditions, among others,
About this update from Cannabis Bioscience International Holdings, Inc.
[{"type":"text","content":"Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas healthcare is experiencing a historic breakthrough with the approval of House Bill 46 (HB 46). Signed into law on June 21, 2025, by Governor Greg Abbott, the expansion of the Texas Compassionate Use Program (TCUP) will cover chronic pain, PTSD, and degenerative neurological conditions, among others, and will directly benefit more than one million Texans, including 300,000 veterans. The law also updates permissible cannabinoid concentrations, signaling a decisive step toward integrating cannabis-based therapies into clinical practice.The Statewide Educational Seminar Series will take place in key cities: UTHealth Houston — November 15, 2025; Austin, TX — December 6, 2025; Dallas, TX — January 17, 2026; El Paso, TX — February 21, 2026. Sessions will address patient registration, prescriber responsibilities, regulatory and liability considerations, reimbursement pathways, and the latest evidence in cannabinoid science.","length":1131,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":688,"url":"https://media.zenfs.com/en/newsfile_64/2b838ba1e379fcc718a4956dfce3e468"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/IrK5Kc81DXb1EoaTOiu4Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEyMDE7Y2Y9d2VicA--/https://media.zenfs.com/en/newsfile_64/2b838ba1e379fcc718a4956dfce3e468","width":550,"height":688}},"href":"https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1.jpg","hrefExternal":true},{"type":"text","content":"Figure 1","length":8,"tagName":"p","attribs":{}},{"type":"text","content":"To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10188/268301_flyer_seminario_tcup_1.jpg","length":136,"tagName":"p","attribs":{}},{"type":"text","content":"CBIH is also entering a stage of accelerated growth driven by key factors such as cannabis tax reductions in California, the expansion of legislation in Texas, regulatory updates in Delaware, and progress toward banking reform. These developments directly strengthen the company's revenue outlook and reinforce its market p...
More updates from Cannabis Bioscience International Holdings, Inc.